Table 1.
Summary of sequencing data.
Sample | Raw Reads (Mb) |
Clean Reads | Clean Reads (Mb) |
Clean Bases (Gb) |
Clean Reads Q30(%) b |
Clean Reads Ratio(%) c |
Total Mapping Ratio d |
Sequencing Depth e |
---|---|---|---|---|---|---|---|---|
S0_1 a | 35.05 | 30,212,592 | 30.21 | 4.53 | 95.28 | 86.19 | 83.80% | 120ⅹ |
S0_2 a | 33.46 | 29,391,054 | 29.39 | 4.41 | 95.27 | 87.84 | 84.39% | 117ⅹ |
S0_3 a | 35.05 | 30,596,914 | 30.60 | 4.59 | 95.65 | 87.29 | 82.51% | 121ⅹ |
S1_1 a | 35.05 | 30,378,866 | 30.38 | 4.56 | 95.57 | 86.66 | 84.01% | 121ⅹ |
S1_2 a | 35.05 | 30,624,970 | 30.62 | 4.59 | 95.94 | 87.37 | 85.72% | 121ⅹ |
S1_3 a | 33.46 | 29,485,096 | 29.49 | 4.42 | 95.78 | 88.12 | 86.05% | 117ⅹ |
a S0_1, S0_2, S0_3: Three biological replicates of SsHADV-1 free sample. S1_1, S1_2, S1_3: three biological replicates of SsHADV-1 infection sample; b Clean Reads Q30(%): Percentages of clean bases whose correct base recognition rates are greater than 99.9% in total bases; c Clean Reads Ratio: Clean reads/raw reads; d Total Mapping Ratio: Genome mapping reads/raw reads; e Sequencing depth: Clean bases/genome size.